
Editor’s note: The biggest IPO in history debuted on June 12 and was celebrated as a generational milestone. Fourteen days later, it's teaching every AI company still waiting to go public a very uncomfortable lesson about what public markets actually do to frontier-technology valuations. OpenAI was supposed to follow SpaceX into the market later this year. Not anymore.
The question isn't whether OpenAI delays. The question is what that means for every company that was planning to price off its success.

PREMIER FEATURE
Trump Ordered the Army to Launch These on American Soil
Under Executive Order 14299, President Trump ordered the U.S. Army and Department of Energy to go on the offensive in a bold, new joint project.
Now the Army and DoE are ready to act…
They’re about to unleash a new secret weapon on American soil to win the AI race: TRISO pebbles.
It will impact the ENTIRE nation.
And one obscure defense contractor could deliver investors a substantial six-month windfall.
But you must move on this opportunity now.
The first deployment of TRISO pebbles is expected to take place before July 4, 2026.
But before we get to that, let's take a quick detour on how the markets are looking and what matters…
3 Movers in 3 Minutes
#1 OpenAI delays IPO. The New York Times reported Thursday night that OpenAI is leaning toward pushing its IPO to 2027, citing internal deliberations involving at least three people close to the talks. CEO Sam Altman has rejected any valuation below $1 trillion as a "non-starter," while CFO Sarah Friar is urging the company to wait, citing ongoing cash burn and the burden of public reporting standards.
#2 Money is flowing hard into healthcare. Eli Lilly (LLY), Johnson & Johnson (JNJ), and AbbVie (ABBV) are among the session's standout gainers. By Thursday's close, 63% of S&P 500 stocks were trading above their 50-day moving averages, up from 50% at the start of June. The market is broadening even as the Nasdaq bleeds.
#3 University of Michigan Sentiment. The final June consumer sentiment reading came in at 49.5, just above the 49.0 consensus and 10.5% above May's reading, marking a meaningful recovery from the lows hit during the Iran conflict. The improvement was concentrated in longer-term expectations, which surged 16% as consumers' concerns about the conflict's economic fallout eased. Still, the index sits 13% below February's pre-conflict level, and nearly 20% below a year ago. The consumer is stabilizing, but not recovered.
3 Signals for Monday
Nonfarm payrolls [June]: Jobs data arrives Thursday July 3, but the week will be dominated by positioning around it. Early forecasts suggest June payrolls growth slowed significantly from May's surprisingly robust 172,000, with the World Cup likely having boosted that figure artificially. Watch how rate-cut odds shift on any downside surprise.
SpaceX (SPCX) technical support: SpaceX opened today near $153, just above its $135 IPO price. Short interest has jumped from 8% to 13% in a single session per Ortex. The $150 floor is being watched closely; a break below IPO price would change the conversation about how every AI IPO prices from here.
Nike (NKE) pre-earnings positioning: Nike reports Q4 fiscal 2026 earnings on Monday June 30 and the stock is hovering near 12-year lows heading into the weekend. The setup is binary: either the new CFO David Denton delivers a credible restructuring roadmap or the stock makes new lows. Every major footwear and apparel name is in sympathy-move range.
And with that out of the way, let's get to today's big story: the IPO that put an entire pipeline on pause.
FROM OUR SPONSORS
Hidden in Tesla's Filing: A $12 Billion "Super Startup"
Pull up Tesla's most recent SEC filing. Page 5.
And you'll see a single line showing $12 billion in revenue from a brand-new "super startup" Elon Musk has been quietly incubating inside Tesla.
But it sits at the center of what Blackstone calls "a $23 trillion investment opportunity."
And on July 22, Elon is expected to pull back the curtain and reveal exactly what he's building.
But Adam O'Dell already knows… and he reveals it all in this urgent video.
The Sip
The Trillion-Dollar Standoff
On June 12, SpaceX priced its IPO at $135 per share, raised more than $85 billion, and became the largest public offering in history. The stock opened at $150, rocketed to $225 within five days, and briefly pushed the company's market cap above $2 trillion. Elon Musk, briefly, became the world's first verified trillionaire.
Fourteen days later, SpaceX trades near $153. That's a 32% retracement from peak to present. And every AI company that had been watching the SpaceX debut as a proof of concept for their own public ambitions is now reading a different lesson from the data.
The most visible consequence arrived Thursday evening, when the New York Times reported that OpenAI is leaning toward delaying its IPO until 2027. The company had confidentially filed an S-1 with the SEC on June 8, hired bankers and lawyers eyeing a late-2026 debut, and entered the quarter as the most anticipated public offering since Saudi Aramco. Now its advisers have presented executives with a stark binary: wait until next year and pursue the $1 trillion valuation, or accept a lower number and list sooner.
CEO Sam Altman's answer, per people close to the talks, was unambiguous. Any reduction from the trillion-dollar target is a "non-starter."
The Pricing Signal Nobody Asked For
To understand why SpaceX's post-IPO retracement matters so much for OpenAI, you have to understand what IPO pricing actually does in a market cycle.
When a landmark company goes public, it doesn't just raise capital for itself. It sets a reference price for every company in the same category that follows. Investors who participated in the SpaceX IPO are now sitting on a 32% loss from the intraday high reached just five days after listing. Those investors, the same institutional buyers that would anchor any OpenAI IPO roadshow, are now holding a bruise. That bruise changes their pricing behavior for the next deal.
OpenAI was valued at $852 billion in a March funding round. Altman's $1 trillion IPO target represents an 18% premium over that number. In a strong market with AI sentiment at peak, that premium is achievable. In a market where the most celebrated AI-adjacent IPO of the decade has already retraced 32% from its high, it is a much harder argument to make to institutional buyers sitting in a room being asked to write nine-figure checks.
CFO Sarah Friar, who has been advocating for the delay, has cited massive ongoing cash burn, compute infrastructure commitments, and the burden of public reporting requirements as reasons to wait. All three are legitimate. But the SpaceX precedent is the freshest wound.
The Quiet Beneficiary
While OpenAI deliberates, one company moved first.
Anthropic confidentially filed for its IPO on June 1, a week before OpenAI announced its own filing. Anthropic raised its last funding round at a valuation of $965 billion, briefly overtaking OpenAI in private-market valuation for the first time. The company has publicly said its IPO will depend on market conditions.
That matters. In a constrained IPO window, being first means capturing demand from investors who want AI exposure and haven't yet been burned by the previous deal. It means setting the reference price rather than being priced against someone else's. And it means the narrative, which company is building the most credible AI product, favors whoever defines the category in the public market before the other one arrives.
The irony is sharp. OpenAI created ChatGPT, defined the modern AI era, and spent three years as the unquestioned market leader. Its IPO was supposed to be the climactic public moment for the entire industry. Instead, Altman's insistence on a trillion-dollar valuation may have handed Anthropic a chance to get there first.
What the Market Is Tracking
OpenAI's financials are more complicated. The company generates approximately $2 billion per month in revenue. It also burns capital at a scale that puts it in perpetual fundraising mode. It recently began a structural conversion from a nonprofit to a for-profit entity, a transition that creates legal and governance complexity that public market investors will need to price. And the Trump administration has asked it to stagger the release of its next major model, GPT-5.6, through a government-approved customer-by-customer preview process, citing national security concerns over frontier AI capabilities.
That last detail, government involvement in how OpenAI can release its own products, is not a small asterisk in a public company's risk factors. It is a fundamental question about how much operational autonomy a publicly listed OpenAI would actually have.
PARTNER SPOTLIGHT
The AI trade that made the Mag 7 soar is starting to crack.
Overpriced giants like Nvidia, Tesla, and Amazon are facing slowing returns — just as smaller, lesser-known names are positioning to take market share.
Waiting could be costly.
Three under-the-radar AI stocks are already showing the potential to outperform the Mag 7 in 2026.
Make sure these alternatives are on your radar before markets open tomorrow.
The MarketSips Takeaway
The OpenAI IPO delay is not a story about one company's reluctance. It's a story about price discovery for an entire asset class. The AI private-market valuations of the past two years were built on a set of assumptions, about growth rates, moats, and investor appetite, that are now being tested in real time by the first company to actually go public.
SpaceX's retracement from peak is the public market's first honest vote on those assumptions. OpenAI is watching that vote and choosing to wait for a friendlier room. The question investors should be asking: is the room going to get friendlier, or does the market need more time to see actual profits before it prices AI companies at a trillion dollars?
What are you watching first: whether SpaceX finds a floor, or whether Anthropic announces its IPO timing?
Until then, sip slowly!
The Market Sip Desk





